These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 21269484)

  • 1. Effect of erythropoietin on level of circulating endothelial progenitor cells and outcome in patients after acute ischemic stroke.
    Yip HK; Tsai TH; Lin HS; Chen SF; Sun CK; Leu S; Yuen CM; Tan TY; Lan MY; Liou CW; Lu CH; Chang WN
    Crit Care; 2011; 15(1):R40. PubMed ID: 21269484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Level and value of circulating endothelial progenitor cells in patients after acute ischemic stroke.
    Yip HK; Chang LT; Chang WN; Lu CH; Liou CW; Lan MY; Liu JS; Youssef AA; Chang HW
    Stroke; 2008 Jan; 39(1):69-74. PubMed ID: 18063830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin for stroke treatment: dead or alive?
    Minnerup J; Wersching H; Schäbitz WR
    Crit Care; 2011; 15(2):129. PubMed ID: 21418552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin improves long-term neurological outcome in acute ischemic stroke patients: a randomized, prospective, placebo-controlled clinical trial.
    Tsai TH; Lu CH; Wallace CG; Chang WN; Chen SF; Huang CR; Tsai NW; Lan MY; Sung PH; Liu CF; Yip HK
    Crit Care; 2015 Feb; 19(1):49. PubMed ID: 25888250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of acute versus convalescent stage high-sensitivity C-Reactive protein level in predicting clinical outcome after acute ischemic stroke and impact of erythropoietin.
    Yeh KH; Tsai TH; Chai HT; Leu S; Chung SY; Chua S; Chen YL; Lin HS; Yuen CM; Yip HK
    J Transl Med; 2012 Jan; 10():6. PubMed ID: 22222005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short- and long-term effects of erythropoietin treatment on endothelial progenitor cell levels in patients with cardiorenal syndrome.
    Jie KE; van der Putten K; Bergevoet MW; Doevendans PA; Gaillard CA; Braam B; Verhaar MC
    Heart; 2011 Jan; 97(1):60-5. PubMed ID: 21071558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between circulating endothelial progenitor cells and outcome in different subtypes of acute ischemic stroke.
    Tsai NW; Hung SH; Huang CR; Chang HW; Chang WN; Lee LH; Wang HC; Lin YJ; Lin WC; Cheng BC; Chiang YF; Su YJ; Tsai TR; Lu CH
    Clin Chim Acta; 2014 Jan; 427():6-10. PubMed ID: 24076252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated Inflammatory Parameter Levels Negatively Impact Populations of Circulating Stem Cells (CD133+), Early Endothelial Progenitor Cells (CD133+/VEGFR2+), and Fibroblast Growth Factor in Stroke Patients.
    Golab-Janowska M; Paczkowska E; Machalinski B; Kotlega D; Meller A; Safranow K; Wankowicz P; Nowacki P
    Curr Neurovasc Res; 2019; 16(1):19-26. PubMed ID: 30706812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin promotes endothelial progenitor cell proliferative and adhesive properties in a PI 3-kinase-dependent manner.
    George J; Goldstein E; Abashidze A; Wexler D; Hamed S; Shmilovich H; Deutsch V; Miller H; Keren G; Roth A
    Cardiovasc Res; 2005 Nov; 68(2):299-306. PubMed ID: 16048724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Level and value of circulating endothelial progenitor cells in patients with acute myocardial infarction undergoing primary coronary angioplasty: in vivo and in vitro studies.
    Chang HW; Leu S; Sun CK; Hang CL; Youssef AA; Hsieh YK; Yang CH; Cheng CI; Chen SM; Chen CJ; Chua S; Chang LT; Wu CJ; Yip HK
    Transl Res; 2010 Oct; 156(4):251-63. PubMed ID: 20875902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDP-choline treatment increases circulating endothelial progenitor cells in acute ischemic stroke.
    Sobrino T; Rodríguez-González R; Blanco M; Brea D; Pérez-Mato M; Rodríguez-Yáñez M; Leira R; Castillo J
    Neurol Res; 2011 Jul; 33(6):572-7. PubMed ID: 21708065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating CD133+CD34+ progenitor cells inversely correlate with soluble ICAM-1 in early ischemic stroke patients.
    Bogoslovsky T; Spatz M; Chaudhry A; Maric D; Luby M; Frank J; Warach S
    J Transl Med; 2011 Aug; 9():145. PubMed ID: 21871109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of circulating endothelial progenitor cells using the modified ISHAGE protocol.
    Schmidt-Lucke C; Fichtlscherer S; Aicher A; Tschöpe C; Schultheiss HP; Zeiher AM; Dimmeler S
    PLoS One; 2010 Nov; 5(11):e13790. PubMed ID: 21072182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The increase of circulating endothelial progenitor cells after acute ischemic stroke is associated with good outcome.
    Sobrino T; Hurtado O; Moro MA; Rodríguez-Yáñez M; Castellanos M; Brea D; Moldes O; Blanco M; Arenillas JF; Leira R; Dávalos A; Lizasoain I; Castillo J
    Stroke; 2007 Oct; 38(10):2759-64. PubMed ID: 17761925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of methods for assessment of circulating endothelial progenitor cells.
    George J; Shmilovich H; Deutsch V; Miller H; Keren G; Roth A
    Tissue Eng; 2006 Feb; 12(2):331-5. PubMed ID: 16548691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of erythropoietin therapy on clinical outcome in patients after acute ischemic stroke: a debatable issue.
    Yuen CM; Sun CK; Leu S; Yip HK
    Crit Care; 2011; 15(3):425. PubMed ID: 21586100
    [No Abstract]   [Full Text] [Related]  

  • 17. EPC mobilization after erythropoietin treatment in acute ST-elevation myocardial infarction: the REVEAL EPC substudy.
    Povsic TJ; Najjar SS; Prather K; Zhou J; Adams SD; Zavodni KL; Kelly F; Melton LG; Hasselblad V; Heitner JF; Raman SV; Barsness GW; Patel MR; Kim RJ; Lakatta EG; Harrington RA; Rao SV
    J Thromb Thrombolysis; 2013 Nov; 36(4):375-83. PubMed ID: 23700090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stromal-derived factor-1[alpha] correlates with circulating endothelial progenitor cells and with acute lesion volume in stroke patients.
    Bogoslovsky T; Spatz M; Chaudhry A; Maric D; Luby M; Frank J; Warach S;
    Stroke; 2011 Mar; 42(3):618-25. PubMed ID: 21257825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of CD45- [CD34+/KDR+] endothelial progenitor cells as juvenile protective factors in a rat model of ischemic-hemorrhagic stroke.
    Decano JL; Moran AM; Giordano N; Ruiz-Opazo N; Herrera VL
    PLoS One; 2013; 8(1):e55222. PubMed ID: 23383116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human choriogonadotropin and epoetin alfa in acute ischemic stroke patients (REGENESIS-LED trial).
    Cramer SC; Hill MD;
    Int J Stroke; 2014 Apr; 9(3):321-7. PubMed ID: 24588854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.